MolEpi meeting: The role of biomarkers and risk scores in predicting incident cirrhosis and hepatocellular cancer in a community population with Type 2 diabetes

Dr Sheila Grecian on “The role of biomarkers and risk scores in predicting incident cirrhosis and hepatocellular cancer in a community population with Type 2 diabetes. The Edinburgh Type 2 Diabetes Study”.

Please note this is TUESDAY.